The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that leads to hospitalization or worse for hundreds of thousands of people in the ...

Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its advanced ...

Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With RSV ...

Respiratory syncytial virus (RSV ... Key exclusion criteria were positivity for the human immunodeficiency virus, concurrent influenza virus infection or bacterial pneumonia, and known or ...

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to ...

The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments for an infection that ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

Health officials in North Dakota are encouraging state residents to prepare for the upcoming respiratory illness season.

The respiratory syncytial virus (RSV) space may have filled up over the past year, but that isn’t deterring Vicebio or its ...